For 1Q25, Macquarie Mid Cap Income Opportunities Fund (Inst.) outperformed the Fund’s benchmark. Click here to read the full commentary.

With the notable exceptions of Novo Nordisk A/S (NYSE: NVO) and Eli Lilly & Co. (NYSE: LLY), biotechnology stocks had a rough ...

Dividend Aristocrats lag the S&P 500 in 2025, but payout growth stays strong and 21 stocks show 10%+ return potential. Find ...

Buffett will retire as Berkshire's CEO this year. Warren Buffett has asked the board of Berkshire Hathaway (NYSE: BRK.A)(NYSE ...